Vice President of Corporate Development, Iterative Health

• Experience in private equity or with the private equity acquisition roll-up model, with a focus on buy-and-build strategies and portfolio company growth, or similar position in healthcare
• Proven experience in managing end-to-end M&A transactions, particularly within healthcare, with a strong understanding of deal structuring, negotiation, and due diligence
• Strong negotiation skills with a track record of achieving favorable terms in high-stakes transactions
• Excellent communication skills, with the ability to manage and influence cross-functional teams and external partners
• Strategic thinker with strong analytical and problem-solving capabilities
• Desire to be wear many hats and a willingness to jump on to various projects as needed

Desirable

• We are looking for a results-driven Vice President of Corporate Development to spearhead our acquisition strategy in the clinical trials market
• This is a high-impact role for an ambitious leader with a background in investment banking, private equity or similar position in a fast-paced biotech company, offering the opportunity to shape our growth strategy and drive major M&A transactions
• The VP of Corporate Development will be instrumental in identifying, assessing, and acquiring clinical trial sites to accelerate company expansion and enhance our position in the clinical trials space
• This role is a high-visibility position designed for a high-performing leader who is eager to make a substantial impact in a rapidly growing organization
• Lead Acquisitions Strategy: Drive the company’s acquisition strategy, identifying and securing high-value clinical trial sites and healthcare assets that align with long-term growth goals
• Market Insight & Target Identification: Utilize deep market expertise and analytical skills to identify acquisition targets with high potential, while remaining responsive to competitive dynamics and industry trends
• Deal Structuring, Negotiation & Execution: Take ownership of the full transaction lifecycle, from structuring deals and performing due diligence to managing financial analyses and negotiating terms, ensuring optimal deal outcomes
• Integration Planning & Execution: Work collaboratively across finance, legal and operational teams to ensure smooth post-acquisition integration, maximizing value and ensuring alignment with overarching strategic goals
• Executive Communication & Stakeholder Management: Develop and deliver compelling acquisition proposals, financial summaries, and performance reports to the executive team and board, ensuring buy-in and alignment with corporate vision
• Risk Management & Compliance: Identify, assess, and mitigate potential financial, regulatory, and operational risks associated with acquisitions

• This role will be accepting applications from November 14, 2024 until November 26, 2024
• Resumes will be reviewed and applicants will receive an update by 5pm ET on Thursday December 5th. Interviews will begin thereafter